• About

    • WHAT WE DO
    • CORE TEAM
  • Projects
  • Partnership
  • News
  • Contacts
HomeSite map
Site map

  • Main
  • About
    • WHAT WE DO
    • CORE TEAM
  • Projects
    • Aldosterone synthase inhibitor
    • Anti-tuberculosis drug
    • Multi-asset R&D
  • Partnership
  • News
    • Target Medicals is among finalists of BiotechMed GenerationS (Tomsk)
    • 2019 BIO International Convention in Philadelphia, PA
    • 2018 BIO International Convention in Boston, MA
    • 2017 BIO International Convention in San-Diego, California
    • BIO-Europe 2016 in Berlin, Germany
    • BIO-Europe 2017 in Cologne, Germany
    • Crystera attends BIO-Europe 2019 (Hamburg, Germany) with oral presentation
    • StartUp Slam on BIO-Europe 2017
    • 2018 Biotech Showcase in San-Francisco, California
    • Target Medicals Group is a finalist of RESI Innovation challenge
    • Presentation of Crystera's progects in Cambridge, UK
    • Crystera is a winner of Patents Power competition by Bayer AG
    • Intertational Aldosterone Conference
    • AstraZeneca, Crystera and The University of Queensland enter into joint pioneering R&D collaboration
    • Target Medicals Group is a finalist of the Start-Up Stadium.
    • MT-Medicals receives a seed round from Primer Capital Venture Fund.
    • Target Medicals is a tenant of Bayer CoLaborator
    • Target Medicals closes a seed-stage venture deal
  • Contacts
  • Search
  • sitemap

  • About
  • Projects
  • Partnership
  • News
  • Contacts
  • Site map

© 2016 Target Medicals LLC